Immunex's Enbrel enrollment program.
V
V
Dowell
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001709:Biotechnology / Q000191:economics*; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000191:economics*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept